Form 4/A · Filed Jun 12, 2026, 01:26 PM UTC
TMCI/TREACE MEDICAL CONCEPTS, INC.
Treace John T. — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | P | buy | 9,891 | $4 | $39,982 | 7,348,439 |
| Jun 10, 2026 | P | buy | 14,715 | $4 | $59,213 | 7,338,548 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-268606